We are live on ! Find out more
HRTX icon

Heron Therapeutics
HRTX

173 hedge funds and large institutions have $242M invested in Heron Therapeutics in 2024 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 67 increasing their positions, 39 reducing their positions, and 38 closing their positions.

New
Increased
Maintained
Reduced
Closed

72% more repeat investments, than reductions

Existing positions increased: 67 | Existing positions reduced: 39

39% more call options, than puts

Call options by funds: $297K | Put options by funds: $214K

5.72% less ownership

Funds ownership: 86.04% → 80.32% (-5.7%)

9% less funds holding

Funds holding: 190 → 173 (-17)

25% less funds holding in top 10

Funds holding in top 10: 4 → 3 (-1)

45% less first-time investments, than exits

New positions opened: 21 | Existing positions closed: 38

47% less capital invested

Capital invested by funds: $454M → $242M (-$211M)

Holders
173
Holders Change
-17
Holders Change %
-8.95%
% of All Funds
2.48%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.04%
New
21
Increased
67
Reduced
39
Closed
38
Calls
$297K
Puts
$214K
Net Calls
+$83K
Net Calls Change
+$332K

Top Buyers

1
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$2.98M
2
TC
Tejara Capital
United Kingdom
+$2.67M
3
Citadel Advisors
Citadel Advisors
Florida
+$2.51M
4
Morgan Stanley
Morgan Stanley
New York
+$2.39M
5
CC
Clearline Capital
New York
+$1.75M

Top Sellers

1
O
OrbiMed
New York
-$22.8M
2
Franklin Resources
Franklin Resources
California
-$15.1M
3
State Street
State Street
Massachusetts
-$4.99M
4
EIM
Essex Investment Management
Massachusetts
-$2.44M
5
PAM
Panagora Asset Management
Massachusetts
-$1.97M
Name Holding Trade Value Shares
Change 		Change in
Stake
Charles Schwab
26
Charles Schwab
California
$2.18M -$98.9K -41,411 -4%
Northern Trust
27
Northern Trust
Illinois
$1.97M +$133K +55,755 +6%
Bank of America
28
Bank of America
North Carolina
$1.9M +$1.25M +521,629 +120%
Millennium Management
29
Millennium Management
New York
$1.86M -$1.19M -500,239 -35%
AQR Capital Management
30
AQR Capital Management
Connecticut
$1.79M +$700K +292,972 +48%
Two Sigma Advisers
31
Two Sigma Advisers
New York
$1.61M +$1.67M +697,871 +615%
Squarepoint
32
Squarepoint
New York
$1.22M +$595K +249,197 +69%
GCP
33
GSA Capital Partners
United Kingdom
$1.02M +$190K +79,680 +18%
RB
34
Richmond Brothers
Michigan
$1.02M +$368K +154,224 +43%
CM
35
CM Management
Florida
$995K +$478K +200,000 +67%
Wellington Management Group
36
Wellington Management Group
Massachusetts
$987K -$59.6K -24,967 -5%
NAM
37
Nexpoint Asset Management
Texas
$947K – – –
ZIM
38
Zacks Investment Management
Illinois
$946K +$27K +11,320 +2%
Fidelity Investments
39
Fidelity Investments
Massachusetts
$859K +$214K +89,601 +26%
HF
40
HRT Financial
New York
$849K +$1.02M +426,817 New
Bank of New York Mellon
41
Bank of New York Mellon
New York
$678K -$259K -108,473 -24%
Jane Street
42
Jane Street
New York
$661K -$44.8K -18,776 -5%
XT
43
XTX Topco
Cayman Islands
$592K +$581K +243,363 +449%
KBC Group
44
KBC Group
Belgium
$576K – – –
BNP Paribas Financial Markets
45
BNP Paribas Financial Markets
France
$549K +$221K +92,425 +50%
AR
46
Apeiron RIA
Texas
$485K +$131K +54,907 +29%
Los Angeles Capital Management
47
Los Angeles Capital Management
California
$439K -$43.1K -18,065 -8%
Barclays
48
Barclays
United Kingdom
$435K +$120K +50,109 +30%
DADC
49
D.A. Davidson & Co
Montana
$425K -$11.7K -4,900 -2%
JP Morgan Chase
50
JP Morgan Chase
New York
$411K +$369K +154,487 +296%
1
2
3 4 5

HRTX Hedge Fund Activity: Q3 2024 in Review

173 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Heron Therapeutics (HRTX) for Q3 2024, worth a combined $242M — down 47% from $454M a quarter earlier.

Sellers outnumbered buyers: 38 funds closed out of HRTX and 21 opened new positions — a net loss of 17 holders — while 39 trimmed existing stakes and 67 added.

The largest buyer was Adage Capital Partners, adding an estimated $2.98M. The largest seller was OrbiMed, exiting entirely with an estimated $22.8M sold.

  • 173 institutional investors held Heron Therapeutics (HRTX) as of Q3 2024, down from 190 in Q2 2024.
  • Funds reported $242M of Heron Therapeutics stock for Q3 2024, down 47% quarter-over-quarter.
  • 21 funds opened new Heron Therapeutics positions in Q3 2024 and 38 closed out, a net change of -17 holders.
  • The largest Heron Therapeutics buyer in Q3 2024 was Adage Capital Partners, an estimated $2.98M added.
  • The largest Heron Therapeutics seller in Q3 2024 was OrbiMed, an estimated $22.8M sold.

Based on aggregated 13F filings for Q3 2024.